Poland· PL-100456858
Verquvo
A vericiguat product containing vericiguatum, registered in Poland by Bayer AG. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Vericiguat is registered in 15 of 19 countries.
Countries holding a registration under ATC C01DX22 (vericiguat), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Vericiguat · ATC C01DX22
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vericiguat costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vericiguat · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$12.83
- ES Spain$9.99
- IT Italy$9.50
The record
At a glance
URPL (Poland)- Active substance
- vericiguatum
- Manufacturer
- Bayer AG
- Country
- Poland (PL)
- ATC code
- C01DX22
- ATC class
- Vericiguat
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin04057598012980
- gtin04057598012966
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vericiguat in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVERQUVOBayer AG, Leverkusen
- SwitzerlandVerquvo 2.5 mg, FilmtablettenBayer (Schweiz) AG
- SpainVERQUVO 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
- FinlandVerquvoBayer AG
- IrelandVerquvo 2.5 mg film-coated tabletsBayer AG
- IcelandVerquvoBayer AG*
- NetherlandsVerquvo 2,5 mg filmomhulde tablettenBayer AG
- NorwayVerquvoBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Verquvo
- Liechtenstein · Verquvo
- Norway · Verquvo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3bf29f74-b250-4187-b21e-a3106df10707 GET /v1/drugs/3bf29f74-b250-4187-b21e-a3106df10707?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "2,5 mg",
"packaging": "Rp ¦ EU/1/21/1561/004 ¦ 141597\n10 tabl. w blistrze perforowanym\nRp ¦ EU/1/21/1561/008 ¦ 141598\n98 tabl. w blistrze\nRp ¦ EU/1/21/1561/009 ¦ 141599\n10 tabl. w blistrze perforowanym\n04057598012980 ¦ Rp ¦ EU/1/21/1561/005 ¦ 141600\n100 tabl. w blistrze perforowanym\nRp ¦ EU/1/21/1561/007 ¦ 141601\n28 tabl. w blistrze\nRp ¦ EU/1/21/1561/003 ¦ 141602\n98 tabl. w blistrze\n04057598012966 ¦ Rp ¦ EU/1/21/1561/001 ¦ 141603\n14 tabl. w blistrze\nRp ¦ EU/1/21/1561/002 ¦ 141604\n28 tabl. w blistrze\nRp ¦ EU/1/21/1561/006 ¦ 141605\n14 tabl. w blistrze\nRp ¦ EU/1/21/1561/010 ¦ 141606\n100 tabl. w blistrze perforowanym\nRp ¦ EU/1/21/1561/011 ¦ 141607\n1 butelka 100 tabl.",
"substance": "vericiguatum 2.5 mg",
"common_name": "vericiguatum",
"pl_product_id": "100456858",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about vericiguat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.